Back to search

Belgium· BE-AMP-SAM661596-00

Deanxit 10 mg - 0.5 mg

A melitracen und psycholeptika product containing melitracen hydrochloride, registered in Belgium by PI Pharma. The same ATC class is registered in 3 of our 19 countries.

ATC N06CA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDeanxit 10 mg - 0.5 mgATCN06CA02REGISTER NO.BE-AMP-SAM661596-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Melitracen und psycholeptika is registered in 3 of 19 countries.

Countries holding a registration under ATC N06CA02 (melitracen und psycholeptika), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 3 of them publish a price we can compare per daily dose

Melitracen und psycholeptika · ATC N06CA02

3 / 19 countries

  • Belgiumprice
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Melitracen Hydrochloride
Manufacturer
PI Pharma
Country
Belgium (BE)
ATC code
N06CA02
ATC class
Melitracen und Psycholeptika
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4744637

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for melitracen und psycholeptika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Melitracen und psycholeptika · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6a1263b7-3e33-43eb-a9e2-425583b2efa1
GET /v1/drugs/6a1263b7-3e33-43eb-a9e2-425583b2efa1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Deanxit 10 mg - 0.5 mg",
  "name_fr": "Deanxit 10 mg - 0.5 mg",
  "name_nl": "Deanxit 10 mg - 0.5 mg",
  "amp_code": "SAM661596-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "0.5000",
    "0.5000"
  ],
  "pack_count": 1,
  "substances": [
    "Melitracen Hydrochloride",
    "Melitracen",
    "Flupentixol Dihydrochloride",
    "Flupentixol",
    "Lactose Monohydrate",
    "Vegetable Oil, Hydrogenated",
    "Betadex"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Melitracen and Psycholeptics",
  "authorisation_numbers": [
    "1637PI0656F003"
  ]
}

See everything about melitracen und psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.